Psychonauts

"Psychedelics can be as important in psychiatry as the microscope in biology or the telescope in astronomy."
Stanislav Grof

Scientific studies and research since the 1950s have shown that psychedelic substances (LSD, psilocybin, DMT, MDMA and others) have great potential in the treatment of mental disorders but also in the self-knowledge and mental development of healthy people. They confirm that these substances are physiologically very safe and without significant side effects or risk of addiction. Yet, as a result of political pressure in the early 1970s, legislation in most of the world considers them to be hazardous drugs without any therapeutic potential.

We join the trend of the last ten years, where, after nearly fifty years of repression, more sensible drug policies are gaining ground and research into psychedelics is resurgent across continents. Renowned universities and hospitals are setting up new research centres, and the number of peer-reviewed articles and studies is growing rapidly. Thanks to new technologies and imaging methods, the mechanism of action of psychedelics on the human brain is better understood, and their therapeutic potential is being confirmed.